A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.

A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.

Bibliographic Details
Main Author:	Peto, T
Format:	Journal article
Language:	English
Published:	1990

Similar Items

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000)

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000)

Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients
by: Inski Yu MD, et al.
Published: (2017-09-01)

Neopterin Changes during Zidovudine Treatment of HIV-1 Infection
by: Hutterer J., et al.
Published: (1990-05-01)

Use of zidovudine.
by: Peto, T
Published: (1989)

Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
by: Marit G A van Vonderen, et al.
Published: (2009-05-01)

Correlation between plasma glucose and hemoglobin A1c in HIV-infected individuals receiving zidovudine and non-zidovudine containing antiretroviral therapy regimens
by: Thanyalak Saetang, et al.
Published: (2020-05-01)

Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.
by: Fillekes, Q, et al.
Published: (2014)

Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
by: Abrams, D, et al.
Published: (1999)

Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
by: Herzmann, C, et al.
Published: (2004)

Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
by: Danis Pertiwi, et al.
Published: (2023-05-01)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
by: Darbyshire, J, et al.
Published: (2000)

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000)

Immediate versus deferred zidovudine.
by: Peto, R, et al.
Published: (1993)

The influence of CD 4+t cells, hiv disease stage and zidovudine on hiv isolation in Bahia, Brazil
by: Carlos Brites, et al.
Published: (1996-02-01)

The influence of CD 4+t cells, hiv disease stage and zidovudine on hiv isolation in Bahia, Brazil
by: Carlos Brites, et al.
Published: (1996-02-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
by: Gibb, D, et al.
Published: (2002)

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries
by: Richard M. Gibson, et al.
Published: (2017-12-01)

N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
by: Soo-Huey Yap, et al.
Published: (2007-12-01)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
by: Xiao-Lei Xu, et al.
Published: (2020-12-01)

Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cords.
by: Andrea Kunz, et al.
Published: (2012-01-01)

Determinants for zidovudine-induced anemia in HIV adult patients: A Thai multicenter study
by: Piyawan Kuwalairat, et al.
Published: (2014-01-01)

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.
by: Lachlan R Gray, et al.
Published: (2013-01-01)

Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines
by: Seiji Kageyama MD, Phd, et al.
Published: (2019-06-01)

Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk
by: Inzaule, S, et al.
Published: (2016)

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
by: Ssali, F, et al.
Published: (2006)

Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass
by: David E. Michalik DO, et al.
Published: (2015-03-01)

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
by: Seligmann, M, et al.
Published: (1994)

Comparison of Preterm Delivery Rates between HIV-infected Pregnant Women Receiving Highly Active Antiretroviral Therapy (HAART) Containing Protease Inhibitors (PIs) and HIV-infected Pregnant Women Receiving Zidovudine Monotherapy
by: Bongkot Chakornbandit, et al.
Published: (2015-09-01)

Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China
by: Wu Y, et al.
Published: (2022-08-01)

Echocardiographic assessment of asymptomatic US Air Force members with early HIV infection
by: Gadiel R. Alvarado, et al.
Published: (2019-11-01)

Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
by: Teshale Ayele Mega, et al.
Published: (2020-03-01)

Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
by: Diego Lins Guedes, et al.
Published: (2021-01-01)

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
by: McClernon Daniel, et al.
Published: (2009-04-01)

Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.
by: Aboulker, J, et al.
Published: (1998)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2007)

Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda
by: Alisen Ayitewala, et al.
Published: (2020-01-01)

HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy.
by: Jambo, K, et al.
Published: (2017)

HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy
by: Kondwani C. Jambo, et al.
Published: (2017-12-01)